IDO1 and neoplasm: IDO1 overexpression leads to Trp depletion, which in turn leads to inhibition of the mammalian target of rapamycin complex (mTORC) pathway and activation of the stress-response general control over nonderepressible (GCN2) kinase in tumor-infiltrating T cells, which both lead to immunosuppression (11).